The stimulation of the formation of inositol phosphates by various cholinergic agonists and antagonists was studied in rat brain cortical slices.
Acetylcholine is one of the major neurotransmitters in brain. The muscarinic cholinergic cascade in brain and other tissues appears to involve the hydrolysis of phosphoinositides to form diacylglycerol and inositol phosphates which can serve as second messengers (Berridge et al., 1983; Michell, 1983) . Although muscarinic cholinergic stimulation can increase ["'Plorthophosphate incorporation into phosphatidylinositol (PI) (Fisher et al., 1983) , the synthesis and breakdown of PI are not always linked (Farese, 1983) . Recent studies have indicated that lithium prevents the dephosphorylation of inositol phosphate (Sherman et al., 1981) . By incubating brain slices in the presence of lithium, the breakdown of PI can be directly followed by measuring the accumulation of inositol phosphate (Berridge et al., 1982) . Therefore, we have developed a method to measure inositol phosphate in brain slices and have characterized the effects of various cholinergic agonists and antagonists on the accumulation of inositol phosphate in rat brain. We report here that acetylcholine and other cholinergic agonists cause a marked increase in inositol phosphate accumulation. Cholinergic stimulation is blocked by atropine, sug-' This work was supported by American Federation for Aging Research Grant AFAR 1576 and by National Institute of Alcohol Abuse and Alcoholism Grant AA06069. We wish to thank Dr. P. Downes for his helpful comments.
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gesting a muscarinic receptor. Certain muscarinic agents such as oxotremorine appear to be partial agonists at this receptor. There is a regional distribution to this response, with the cerebral cortex, hippocampus, and striatum exhibiting the greatest responses. The cholinergic stimulation of inositide breakdown probably represents the initial step in a cascade which leads to the activation of protein kinases which alter membrane conductances and nerve firing.
Materials and Methods
All drugs used in this study were purchased from Sigma Chemical Co. with the exception of pirenzepine, which was kindly donated by L. Slices of cortex (0.2 ml of packed tissue) which had been incubated with [3H]inositol for 1 hr were extracted as described above except that 0.35 ml of 1 N HCl was added to the slices instead of water to ensure complete extraction of these acidic lipids (Dowries and Michell, 1982) . The upper phase was removed and the lower phase was evaporated to dryness. Using the method of Clarke and Dawson (1981) , the residue was taken up in 0.75 ml of methylamine reagent (methylamine:methanol:water:butanol; 5:4:3:1) and incubated for 60 min at 53°C. The reagent was subsequently removed by evaporation and the residue was resuspended in 1 ml of water. This mixture was extracted with 1.2 ml of n-butanol:petroleum ether:ethyl formate (20:4:1). After removing the upper phase, the lower phase was washed again with 0.75 ml of the same solvent.
An aliquot (0.70 ml) of the lower phase containing the water-soluble products from deacylation of phospholipids was then diluted to 3 ml with water prior to chromatography on a Dowex-1 column as previously described. active peak was associated with PI and not the other major lipid components of the membranes. To further identify the lipids which were labeled, lipid extracts were deacylated and the water-soluble products were separated by anion exchange chromatography.
The label was incorporated into three fractions corresponding to hydrolysis products of PI, phosphatidylinositol 4-phosphate, and phosphatidylinositol 4,5-bisphosphate in a ratio of 85:10:5.
To characterize further the incorporation of ["Hlinositol into brain slices, we studied the effect of [3H]inositol concentration. Incorporation was linear up to approximately 100 nM and then began to fall off (Fig. 2) . Our studies of the breakdown of inositides were done using a prelabeling concentration of ["HI inositol in the range of 100 to 200 nM. The incorporation studies described here indicate that ["Hlinositol is specifically incorporated into inositol lipids in rat cerebral cortical slices.
Release it with phospholipase C (bacillus cereus, Sigma). The standard inositol l-phosphate we prepared was eluted at the same concentration of formate as that found released from stimulated cortical slices. Thus, as in other peripheral tissues, the stimulation of inositide hydrolysis in the presence of lithium results in the accumulation of inositol phosphate in rat brain cortex (Berridge et al., 1982; Brown and Brown, 1983 Although there was a hint of stimulated release at 1 min, there was a significant increase in release at 5 min which continued linearly for about 15 min (Fig. 3) . Stimulated release continued to increase at a much slower rate beyond 15 min reaching a maximum of approximately 40% between 60 and 90 min. Nonstimulated release was approximately 12 to 17% throughout the time period studied.
Effects of cholinergic agonists. Complete dose response curves to a series of cholinergic agonists were performed. Marked differences in efficacy and potency were found. Acetylcholine, carbachol, methacholine, and muscarine were found to be the most effective agonists (Table I , Fig. 4 ). Bethanechol had intermediate activity, and arecoline, pilocarpine, and oxotremorine were relatively weak agonists. These results indicate that there are striking differences in the ability of various cholinergic agonists to stimulate inositol lipid breakdown which are not related to their potency (Table I) .
To characterize the apparent partial agonist activity of oxotremorine, a concentration-effect curve was done in the presence and absence of a maximally stimulating concentration of carbachol. Indicative of a partial agonist, oxotremorine caused an increase in the release of inositol phosphate by itself while decreasing the ability of carbachol to stimulate release down to the maximum induced by oxotremorine alone (Fig. 5) . Similar results were obtained with pilocarpine.
These results suggest that oxotremorine, pilocarpine, arecoline, and bethanechol are partial agonists at this cholinergic receptor. The properties of the cholinergic receptor responsible for mediating inositol lipid breakdown were investigated by using various cholinergic antagonists. Scopolamine and atropine (1   PM) completely blocked the release of inositol phosphate induced by 100 PM acetylcholine (Fig. 6) . Gallamine, hexamethonium, and d-tubocurarine had no effect on acetylcholine-stimulated inositol phosphate release at a concentration of 1 PM (Fig. 6 ). In addition, pirenzepine, a selective M1 antagonist, blocked the carbachol (100 PM)-stimulated release of inositol phosphate with an ED," of approximately 0.1 pM (Fig. 7) . None of the antagonists had any effect on nonstimulated release at this concentration.
In addition, the nicotinic receptor agonist l,l-dimethyl-4-phenylpiperazinium iodide had no effect on the release of inositol phosphate at concentrations up to 1 mM. These results indicate that the cholinergic receptor which mediates inositide breakdown in brain slices is muscarinic. Brain regional characterization of carbachol-stimulated inositide breakdown.
Nine separate brain regions were analyzed for their ability to form inositol phosphate in the presence and absence of a maximally stimulating concentration of carbachol. There were large differences in the regional response to carbachol (Fig. 8) . Striatum, cerebral cortex, hippocampus, and olfactory bulb showed the largest responses. Frontal, parietal, and occipital cortex showed approximately equal responses. The cerebellum had the lowest stimulated inositol phosphate release, and the brainstem and hypothalamus were intermediate in responsiveness.
Calcium dependence of carbachol-stimulated inositide breakdown. Many studies have suggested that the increased metabolism of PI induced by a variety of agents may be involved in the control of calcium gating (Michell, 1975) . If this were true in brain slices, one would expect that the response produced by Vol. 4, No. 12, Dec. 1984 The release of [3H]inositol phosphate after 60 min in the presence of agonists was determined as described under "Materials and Methods."
The amount of radioactivity found in the inositol phosphate fraction at time zero was taken as the blank and subtracted from both nonstimulated and stimulated values. To determine the curve for acetylcholine, 10 pM eserine was added. carbachol would be independent of the extracellular calcium concentration.
We have investigated the calcium dependence of carbachol-stimulated inositide breakdown using the present method. Removal of calcium from the incubation medium still allowed a robust response in the presence of carbachol. However, addition of calcium to concentrations as low as 0.1 M caused a significant increase in this response (Fig. 9) . Addition of calcium seemed to increase basal release slightly, but this effect did not reach statistical significance (analysis of variance, p > 0.05). When EGTA (200 FM) was added to the buffer, no significant stimulation of inositol lipid breakdown was observed. Berridge et al., 1982; Brown and Brown, 1983; Putney et al., 1983) . We have characterized this response in rat brain slices by following the accumulation of inositol phosphate. During the characterization of this method, we have made modifications to previous methods (Berridge et al., 1982; Berridge, 1983) which allow a more rigorous analysis of the effects of various agents on the breakdown of inositides in brain tissue. In particular, our decision to express our data as percentage of release corrects for variations in the amount of slices incubated in each tube (i.e., protein). This modification allows experiments to be done on the linear portion of the protein curve.
The muscarinic receptor-stimulated accumulation of inositol phosphates could be due to hydrolysis of any or all of the inositol lipids. Recent studies in other tissues have suggested that the initial receptor-stimulated event is the hydrolysis of the polyphosphoinositides to release inositol polyphosphates which are then rapidly dephosphorylated to inositol l-phosphatase (Berridge et al., 1983) . Due to inhibition of inositol lphosphatase by lithium (Berridge et al., 1982) , inositol lphosphate accumulates under conditions of receptor activation. Thus, it is not clear which of the inositol lipids is hydrolyzed during muscarinic receptor stimulation in rat brain slices. The differences in efficacy for hydrolysis of inositol lipids by various muscarinic receptor agonists which we obtained in rat brain slices agree well with those of Fisher et al. (1983) using 32Pi incorporation into guinea pig synaptosomal inositol lipids and appear to be related to the ability of agonists to induce conformational changes in the muscarinic receptor which subsequently stimulate the hydrolysis of inositol lipids (Fisher et al., 1984) . Thus, muscarinic receptor stimulation in brain appears to involve the rapid hydrolysis and resynthesis of inositol lipids. Vol. 4, No. 12, Dec. 1984 
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The muscarinic receptor-stimulated breakdown of inositide as shown in this study appears to be calcium sensitive. Other investigators have suggested that the muscarinic receptor stimulation of 32Pi incorporation into PI in brain is calcium dependent (Griffin et al., 1979; Fisher and Agranoff, 1980) . Thus, our results suggest that inositide breakdown may not be associated with calcium mobilization in brain, unlike that found for many peripheral tissues (Kirk et al., 1981; Billah and Lapetina, 1982; Weiss et al., 1982) . However, we cannot exclude the possibility that one of the polyphosphoinositides may be preferentially hydrolyzed in a calcium-independent step (Berridge et al., 1983) . Results from other tissues suggest that phosphatidylinositol 4-phosphate or phosphatidylinositol 4,5-bisphosphate may be broken down first (Berridge et al., 1983; Putney et al., 1983) . The polyphosphoinositides represented only 15% of the total ["Hlinositol incorporated into brain slice phosphoinositides. It is possible that the specific calcium-independent breakdown of one of the polyphosphoinositides would not be detected in brain slices.
Inositol lipids have been shown to be hydrolyzed to inositol phosphates and diacylglycerol (DAG) in a number of peripheral tissues (Michell, 1983) . DAG formed from thrombin stimulation of inositide breakdown activates a calcium phospholipiddependent protein kinase in platelets causing aggregation and serotonin release (Sano et al., 1983) . Calcium phospholipiddependent protein kinase activity is higher in brain than in any other tissue (Kuo et al., 1980) and is likely to be activated by DAG formed from muscarinic receptor stimulation of inositide breakdown.
Thus, cholinergic stimulation of inositol lipid hydrolysis is likely to be the first step in an important intraneuronal cascade.
The cholinergic stimulation of inositide breakdown in brain slices is clearly muscarinic.
Muscarinic agonists stimulate the response, whereas nicotinic agonists do not (e.g., l,l-dimethyl-4-phenylpiperazinium); muscarinic antagonists block the response (e.g., atropine and scopolamine), and nicotinic antagonists do not alter the response. Although gallamine has been reported to modify muscarinic receptor binding at high concentrations (Stockton et al., 1983) , the concentration we used (1 pM) would be selective for nicotinic sites. Recent binding studies have suggested that there are muscarinic receptor subtypes (Hammer et al., 1980) . One of these muscarinic receptor subtypes is likely to be coupled to inositide hydrolysis. We found large responses in the striatum, cerebral cortex, and hippocampus. These findings are consistent with the regional distribution of M1 receptors (Hammer et al., 1980; Watson et al., 1984) . In addition, pirenzepine, a selective M, antagonist (Potter et al., 1984; Watson et al., 1984) , blocked carbachol stimulation of inositol phosphate release. However, more data are required to determine definitively the subtype of muscarinic receptor coupled to inositide hydrolysis. Variations in agonist efficacy, selective antagonists, and/or modifiers may be important tools for the characterization of central muscarinic receptor subtypes. Clearly, one type of central muscarinic receptor is coupled to hydrolysis of inositides and this is likely to be the initial step in an intraneuronal cascade including the activation of the calcium phospholipid-dependent protein kinase.
